Sandbox:Preeti: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 8: Line 8:
!Differentiating physical exam findings
!Differentiating physical exam findings
!Differentiating Labs
!Differentiating Labs
|-
| rowspan="3" |'''Physiological variation'''
| colspan="2" |Birth
|
|
|
|-
| colspan="2" |Adult
|
|
|
|-
| colspan="2" |Pregnancy
|
|
|
|-
|-
| rowspan="10" |'''Infections'''  
| rowspan="10" |'''Infections'''  
| rowspan="4" |Bacterial  
| rowspan="4" |'''Bacterial'''
| rowspan="2" |Syphilis
| rowspan="2" |Syphilis
|
|
Line 46: Line 29:
|
|
|-
|-
| rowspan="4" |Viral  
| rowspan="4" |'''Viral'''
|infectious mononucleosis
|infectious mononucleosis
|
|
Line 67: Line 50:
|
|
|-
|-
|Mycobacterial
|'''Mycobacterial'''
|tuberculosis
|tuberculosis
|
|
Line 73: Line 56:
|
|
|-
|-
|Parasitic  
|'''Parasitic'''
|toxoplasmosis
|toxoplasmosis
|
|
Line 79: Line 62:
|
|
|-
|-
| rowspan="18" |'''Secondary'''
| rowspan="4" |'''Autoimmune'''
| rowspan="2" |'''Infection'''
|'''Systemic lupus erythematosus'''
|Acute
|
|
|
|
|
|
|
|-
|-
|Chronic
|'''Sjögren's syndrome'''
|
|
|
|
|
|
|
|-
|-
| rowspan="4" |'''Connective tissue disorders'''
|'''Hydantoin derivatives'''
|RA
|
|
|
|
|
|
|
|-
|-
|JRA
|'''Sarcoidosis'''
|
|
|
|
|
|
|
|-
|-
|IBD
| rowspan="6" |'''Neoplasms'''
| colspan="1" rowspan="1" |'''Hodgkin's disease'''
|
|
|
|
|
|
|
|-
|-
|Chronic hepatitis
| colspan="1" rowspan="1" |'''Chronic lymphocytic leukemia'''
|
|
|
|
|
|
|
|-
|-
| rowspan="4" |'''Drug induced'''
| colspan="1" rowspan="1" |'''Small cell carcinoma of the lung'''
|Steriod
|
|
|
|
|
|
|
|-
|-
|Lithium
| colspan="1" rowspan="1" |'''Malignant histiocytosis'''
|
|
|
|
|
|
|
|-
|-
|Beta agonists
| colspan="1" rowspan="1" |'''Melanoma'''
|
|
|
|
|
|
|
|-
|-
|Cytokines
| colspan="1" rowspan="1" |'''Germ cell neoplasms'''
|
|
|
|
|-
| rowspan="2" |'''Marrow stimulation'''
|Hemolytic anemia
|
|
|
|
|
|
|-
|-
|Immature thrombocytopenia
| rowspan="5" |'''Other conditions'''
|
| colspan="1" rowspan="1" |'''Reactive lymphoid hyperplasia'''
|
|
|
|-
| colspan="2" |'''Post splenectomy'''
|
|
|
|
|
|
|-
|-
| rowspan="5" |'''Metabolic'''
| colspan="1" rowspan="1" |'''Lymphomatoid granulomatosis'''
|Diabetic coma
|Diabetic coma
|
|
Line 155: Line 137:
|
|
|-
|-
| colspan="1" rowspan="1" |'''Dermatopathic lymphadenopathy'''
|Acidosis
|Acidosis
|
|
Line 160: Line 143:
|
|
|-
|-
| colspan="1" rowspan="1" |'''Angioimmunoblastic lymphadenopathy'''
|Thyroid strom
|Thyroid strom
|
|
Line 165: Line 149:
|
|
|-
|-
| colspan="1" rowspan="1" |'''Giant lymph node hyperplasia (Castleman disease)'''
|Acute Gout
|Acute Gout
|
|
Line 170: Line 155:
|
|
|-
|-
|
|
|Seizures
|Seizures
|
|

Revision as of 15:24, 19 December 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]

Differentiating Symptoms Differentiating physical exam findings Differentiating Labs
Infections Bacterial Syphilis
Brucellosis
Viral infectious mononucleosis
cytomegalovirus
human immunodeficiency virus
cat scratch fever
Mycobacterial tuberculosis
Parasitic toxoplasmosis
Autoimmune Systemic lupus erythematosus
Sjögren's syndrome
Hydantoin derivatives
Sarcoidosis
Neoplasms Hodgkin's disease
Chronic lymphocytic leukemia
Small cell carcinoma of the lung
Malignant histiocytosis
Melanoma
Germ cell neoplasms
Other conditions Reactive lymphoid hyperplasia
Lymphomatoid granulomatosis Diabetic coma
Dermatopathic lymphadenopathy Acidosis
Angioimmunoblastic lymphadenopathy Thyroid strom
Giant lymph node hyperplasia (Castleman disease) Acute Gout
Seizures